BJCT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BJCT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-16), Bioject Medical Technologies's share price is $0.0001. Bioject Medical Technologies's Book Value per Share for the quarter that ended in Sep. 2011 was $-0.45. Hence, Bioject Medical Technologies's PB Ratio of today is .
The historical rank and industry rank for Bioject Medical Technologies's PB Ratio or its related term are showing as below:
The historical data trend for Bioject Medical Technologies's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioject Medical Technologies Annual Data | |||||||||||||||||||||
Trend | Mar01 | Mar02 | Dec03 | Dec04 | Dec05 | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | |||||||||||
PB Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
Bioject Medical Technologies Quarterly Data | ||||||||||||||||||||
Dec06 | Mar07 | Jun07 | Sep07 | Dec07 | Mar08 | Jun08 | Sep08 | Dec08 | Mar09 | Jun09 | Sep09 | Dec09 | Mar10 | Jun10 | Sep10 | Dec10 | Mar11 | Jun11 | Sep11 | |
PB Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Instruments & Supplies subindustry, Bioject Medical Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Bioject Medical Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bioject Medical Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Bioject Medical Technologies's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Sep. 2011) |
= | 0.0001 | / | -0.445 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bioject Medical Technologies (OTCPK:BJCT) PB Ratio Explanation
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Bioject Medical Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
James C Gale | director | 152 W 57TH STREET, 19TH FLOOR, NEW YORK NY 10019 |
Sanders Morris Harris Inc/fa | 10 percent owner, other: See General Remarks | 600 TRAVIS, SUITE 5900, HOUSTON TX 77002 |
David S Tierney | director | C/O ABLE LABORATORIES, INC., 6 HOLLYWOOD COURT, CN 1013, SOUTH PLAINFIELD NJ 07080 |
Edward L Flynn | director, 10 percent owner | 211 SOMERVILLE ROAD RTE 202N, BEDMINISTER NJ 07921 |
Life Sciences Opportunities Fund Ii Lp | 10 percent owner | 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019 |
Lof Partners Llc | other: See general remarks | 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019 |
Life Sciences Opportunities Fund Instittutional Ii Lp | 10 percent owner | 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019 |
Randal D Chase | director | 28 GEORGIA COURT, RICHMOND HILL A6 L4E ON7 |
Brigid Makes | director | 20245 SW 95TH AVENUE, TUALATIN OR 97062 |
J Michael Redmond | officer: Sr. VP Bus Dev. | 10 CANTERBURY ROAD, WINDHAM NH 03087 |
Elan Corp Plc | 10 percent owner | TREASURY BUILDING, LOWER GRAND CANAL STREET, DUBLIN 2 L2 00000 |
Elan International Services Ltd | 10 percent owner | C/O TREASURY BUILDING, LOWER GRAND CANAL STREET, DUBLIN L2 2 |
Elan Pharmaceutical Investments Ltd | 10 percent owner | 102 ST JAMES COURT, FIETSS SMITH FL BERM D0 9999999999 |
John P Gandolfo | officer: CFO | 62 TERRACE ROAD, WAYNE NJ 07470 |
Grace K Fey | director | 1210 CROMWELL ROAD, HALIFAX NOVA SCOTIA A5 B3H4L2 |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.